TranS1 Reports Operating Results for the Fourth Quarter of 2011, Issues First Quarter 2012 Guidance

Published: Mar 09, 2012

WILMINGTON, N.C., March 8, 2012 (GLOBE NEWSWIRE) --TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region, today announced its financial results for the fourth quarter ended December 31, 2011.

Back to news